News | June 30, 2011

Long Beach Hospital Advances Care of Coronary Artery Disease With New Optical Coherence Tomography Platform

June 30, 2011 — The MemorialCare Heart and Vascular Institute (MHVI) at Long Beach Memorial has acquired the C7-XR OCT intravascular imaging system from St. Jude Medical. It is an imaging technology platform that aids physicians in the diagnosis and treatment of cardiovascular disease. Using optical coherence tomography (OCT), the system utilizes near-infrared light to create images that go beyond older coronary imaging technologies -- such as fluoroscopy and intravascular ultrasound (IVUS) -- offering cardiologists an assessment method with enhanced clarity for their patients with coronary artery disease.

The system allows physicians at Long Beach Memorial to visualize and measure important vessel characteristics otherwise invisible or difficult to assess with previous intracoronary imaging technology. It can assist physicians in stent selection by providing them with precise measurements of lesion dimensions and vessel size and structure.

“The C7-XR System can be especially important for the assessment of stent placement because the high-resolution images show precisely how the stent is holding the artery open and whether it is positioned correctly against the artery wall, optimizing treatment and follow-up strategies,” said Rex Winters, M.D., medical director of invasive technology, MHVI.

In addition to guiding stent selection, the system provides physicians with post-stenting information, potentially minimizing the risk of repeat revascularization, where the patient would need to have another surgery to restore blood flow to an organ or tissue. At follow-up, the OCT technology provides detailed information regarding the inner lining of the vessel and whether there is a reoccurrence of the blood vessel narrowing.

The OCT technology platform creates images with 10 times the resolution of IVUS. The superior resolution and depth of focus found in OCT images aids in optimizing stent selection, evaluating stent apposition and the precise assessment of lesion morphology.

The C7-XR system with the C7 Dragonfly imaging catheter was launched in Europe in May 2009 and the M3 OCT imaging system had been the only commercially available intracoronary OCT imaging device in the world. The C7-XR is commercially available in the United States.

For more information:

Related Content

Abbott Initiates ILUMIEN IV Trial
News | Optical Coherence Tomography (OCT) | April 11, 2018
Abbott today announced the initiation of a clinical trial evaluating long-term outcomes of patients who undergo stent...
OCT, optical coherence tomography, coronary stent implantation, superior resolution, TCT 2016, ILLUMIEN III OPTIMIZE PCI Trial
News | Optical Coherence Tomography (OCT) | October 31, 2016
Optical coherence tomography (OCT) provides safe and improved guidance for patients undergoing percutaneous coronary...
Avinger, U.S. Department of Veterans Affairs, VA, Lumivascular technology, FSS Contract Award
News | Optical Coherence Tomography (OCT) | September 27, 2016
Avinger Inc. recently announced the company has received an FSS Contract Award from the U.S. Department of Veterans...
OCT, ORBID study
News | Optical Coherence Tomography (OCT) | May 16, 2016
May 16, 2016 — In a new study using...
Overlay Init